The promise of gene therapy in gastrointestinal and liver diseases
- 1 May 2003
- Vol. 52 (90002) , 49ii-54
- https://doi.org/10.1136/gut.52.suppl_2.ii49
Abstract
Gene therapy consists of the transfer of genetic material to cells to achieve a therapeutic goal. In the field of gastroenterology and hepatology gene therapy has produced considerable expectation as a potential tool in the management of conditions that lack effective therapy including non-resectable neoplasms of the liver, pancreas and gastrointestinal tract, chronic viral hepatitis unresponsive to interferon therapy, liver cirrhosis, and inflammatory bowel disease.Keywords
This publication has 56 references indexed in Scilit:
- In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunityGene Therapy, 2000
- Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12Cancer Gene Therapy, 1999
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Retroviral Vectors for Liver-directed Gene TherapySeminars in Liver Disease, 1999
- Gene Transfer into the CNS Using Recombinant Adeno-associated Virus: Analysis of Vector DNA Forms Resulting in Sustained ExpressionJournal of Drug Targeting, 1999
- Adenovirus-Mediated Transduction of Intestinal CellsIn VivoHuman Gene Therapy, 1998
- In VivoGene Transfer and Expression in Rat Stomach by Submucosal Injection of Plasmid DNAHuman Gene Therapy, 1996
- Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene deliveryHuman Molecular Genetics, 1994
- Improving Access to Intestinal Stem Cells as a Step Toward Intestinal Gene TransferHuman Gene Therapy, 1994
- Inhibition of hepatitis B virus by antisense oligodeoxynucleotidesThe Lancet, 1991